- decreased total retina thickness / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal retina morphology / IMPC
- decreased lymphocyte cell number / IMPC
- increased circulating cholesterol level / IMPC
- abnormal retina outer nuclear layer morphology / IMPC
- decreased circulating calcium level / IMPC
- increased circulating phosphate level / IMPC
- increased neutrophil cell number / IMPC
- decreased hemoglobin content / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- decreased cornea thickness / IMPC
- increased red blood cell distribution width / IMPC
- increased blood urea nitrogen level / IMPC
- abnormal heart left ventricle morphology / IMPC
- decreased exploration in new environment / IMPC
- increased circulating HDL cholesterol level / IMPC
- abnormal auditory brainstem response / IMPC
- increased circulating triglyceride level / IMPC
C57BL/6N-Adipor1tm1a(EUCOMM)Hmgu/H
Status | Available to order |
EMMA ID | EM:08491 |
International strain name | C57BL/6N-Adipor1tm1a(EUCOMM)Hmgu/H |
Alternative name | HEPD0757_5_B12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Adipor1tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Adipor1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0757_5_B12. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased brown adipose tissue amount / MGI
- increased white adipose tissue amount / MGI
- hypoactivity / MGI
- hyperglycemia / MGI
- abnormal glucose homeostasis / MGI
- increased circulating insulin level / MGI
- abnormal lipid homeostasis / MGI
- no abnormal phenotype detected / MGI
- decreased energy expenditure / MGI
- decreased adiponectin level / MGI
- increased circulating cholesterol level / MGI
- impaired glucose tolerance / MGI
- insulin resistance / MGI
- increased susceptibility to weight gain / MGI
- increased percent body fat/body weight / MGI
- increased circulating glucose level / MGI
- abnormal enzyme/coenzyme activity / MGI
- increased circulating leptin level / MGI
- increased liver triglyceride level / MGI
- abnormal adaptive thermogenesis / MGI
- impaired adaptive thermogenesis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).